Bank of New York Mellon »

Nurix Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.3M 159k 14.70
2023-12-31 $1.8M 173k 10.32
2023-09-30 $1.3M 170k 7.86
2023-06-30 $1.7M 166k 9.99
2023-03-31 $1.4M 158k 8.88
2022-12-31 $1.8M 161k 10.98
2022-09-30 $2.4M 159k 15.38
2022-06-30 $1.7M 136k 12.67
2022-03-31 $1.5M 104k 14.00
2021-12-31 $3.0M 104k 28.95
2021-09-30 $2.9M 98k 29.98
2021-06-30 $2.1M 78k 26.51
2021-03-31 $2.1M 67k 31.09
2020-12-31 $1.5M 44k 32.90
2020-09-30 $974k 28k 34.91